Adipotide
Prohibitin-targeting peptide · FTPP
A proapoptotic peptide studied in preclinical models, designed to target the vasculature supporting white adipose tissue. Preclinical only, with reported renal effects in animal studies and no approved human use.
Tracking and educational reference only, on values you enter yourself. Not medical advice or a dosing recommendation.
Half-life
Not established in a public source. Half-life is an educational pharmacology figure, drawn from public sources, and is not a schedule or dosing instruction.
Storage & handling
Not approved for human use; no public label defines handling.
References
- PubChem compound record
- Diabetes 2012: weight-independent improvement of glucose tolerance from a targeted proapoptotic peptide
- J Control Release 2013: comparative study of nanoparticle-targeted therapeutics as obesity medication
Read the source
Related in GLP-1 / Metabolic
Educational reference only, compiled from public sources. Not medical advice, diagnosis, treatment, or a dosing recommendation, and not a recommendation to use any compound. Many compounds listed are research materials not approved for human use. Consult a qualified professional.